Yersinia pseudotuberculosis infection

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:659707A28.2
Who is this for?
Show terms as
1FDA treatments1Specialists8Treatment centers1Financial resources

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Y. pseudotuberculosis infection
Orphanet ↗NORD ↗

Treatments

1 available

Priftin

Rifapentine· Hoechst Marion Roussel
PRIFTIN is indicated in adults and pediatric patients 2 years and older for the treatment of latent tuberculosis infection caused by Mycobacterium tuberculosis in patients at high risk of progression …

PRIFTIN is indicated in adults and pediatric patients 2 years and older for the treatment of latent tuberculosis infection caused by Mycobacterium tuberculosis in patients at high risk of progression to tuberculosis disease in combination with isoniazid

View Details →FDA Label ↗Copay Card ↗Patient Assistance ↗

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Yersinia pseudotuberculosis infection at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Yersinia pseudotuberculosis infection community →

Specialists

1 foundView all specialists →
SM
Siv Fonnes, MD
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Priftin(Rifapentine)— Hoechst Marion Roussel

Travel Grants

No travel grants are currently matched to Yersinia pseudotuberculosis infection.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Yersinia pseudotuberculosis infectionForum →

No community posts yet. Be the first to share your experience with Yersinia pseudotuberculosis infection.

Start the conversation →

Latest news about Yersinia pseudotuberculosis infection

No recent news articles for Yersinia pseudotuberculosis infection.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Yersinia pseudotuberculosis infection

Which specialists treat Yersinia pseudotuberculosis infection?

1 specialists and care centers treating Yersinia pseudotuberculosis infection are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.